Posted by Michael Wonder on 11 Oct 2025
SQ Innovation announces FDA approval of Lasix ONYU for treatment of edema in heart failure
8 October 2025 - -- SQ Innovation today announced that the US FDA has approved its drug-device combination Lasix ONYU (furosemide injection) for the treatment of oedema in adult patients with chronic heart failure.
Lasix ONYU was developed to enable subcutaneous infusion of furosemide outside the health care setting for selected patients, as prescribed by a clinician without the need for a healthcare professional to administer the drug.
